KAITLIN VAUGHN: Open Payments
NPI 1508219262 · LAKEWOOD RANCH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,316 in 99 payments from 16 companies in 2025. Trend: 2023 $1,138 · 2024 $2,045 · 2025 $3,316
Food & beverage: $3,235Education: $81
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $648 |
| Arcutis Biotherapeutics, Inc. | 11 | $523 |
| Regeneron Healthcare Solutions, Inc. | 19 | $506 |
| Janssen Biotech, Inc. | 17 | $263 |
| Novartis Pharmaceuticals Corporation | 8 | $239 |
| Galderma Laboratories, L.P. | 9 | $226 |
| UCB, Inc. | 5 | $224 |
| Lilly USA, LLC | 4 | $209 |
| E.R. Squibb & Sons, L.L.C. | 2 | $129 |
| Verrica Pharmaceuticals Inc. | 1 | $122 |
Products named: DUPIXENT, SKYRIZI, Zoryve, TREMFYA, RINVOQ, Bimzelx, NEMLUVIO, Rhapsido.
Industry payments across FL — which companies pay providers there.
